SCHEMBL932746

SCHEMBL932746

NC(CO)CCC(=O)O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL289109 1.00
SCHEMBL6515001 1.00
SCHEMBL289090 0.86 ENPEP (0.76)
Succinic Acid SCHEMBL22346000 0.83 LMNA (0.53)
SCHEMBL288592 0.82 ENPEP (0.64)
SCHEMBL28208979 0.82 ENPEP (0.64)
SCHEMBL147434 0.79
SCHEMBL147435 0.79
SCHEMBL42056 0.79 ENPEP (0.62)
SCHEMBL288129 0.79 ENPEP (0.62)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 136 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-120115188-A Vanadium-based catalyst, preparation method thereof and application thereof in catalyzing oxidation of 5-hydroxymethylfurfural to prepare 2, 5-diformylfuran 中国科学院大连化学物理研究所 2025-06-10 CN claimed
CN-118178373-A Application of 4-amino-5-hydroxyvaleric acid in preparing medicament for treating and/or relieving diseases or symptoms caused by serotonin deficiency 广东省农业科学院茶叶研究所 2024-06-14 CN claimed
CN-116716016-A Moisture-proof and dust-proof epoxy paint for wood and preparation method thereof 史丹龙涂料(常州)有限公司 2023-09-08 CN claimed
CN-104926920-B Protein and peptide drugs N-terminal pinpoints polyethyleneglycol modified method 浙江医药高等专科学校 2019-08-09 CN claimed
CN-104926920-A Protein polypeptide drug N-terminal fixed-point polyethylene glycol modification method ZHEJIANG PHARMACEUTICAL COLLEGE 2015-09-23 CN claimed
CN-122121859-A Composition containing mycosporine 2026-05-29 CN disclosed
US-20260144888-A1 USE OF A LIQUID AQUEOUS COMPOSITION FOR SOLUBILIZATION AND STABILIZATION OF AN ANTIBODY-DRUG CONJUGATE PIERRE FABRE MEDICAMENT (FR) 2026-05-28 US disclosed
EP-3697208-B1 HIGH-FIDELITY LONG-TERM STORAGE OF BIOLOGICAL MATERIAL CENTRE NAT RECH SCIENT (FR) 2026-04-22 EP disclosed
EP-4687443-A1 METHOD FOR FUNCTIONALISING A SOLID SUBSTRATE WITH A PEPTIDE CONJUGATE Genepep (FR) 2026-02-11 EP disclosed
US-20250369024-A1 Acyloin Condensation Reactions, Enzymes, and Products Thereof MOJIA BIOTECH PTE LTD (SG) 2025-12-04 US disclosed
EP-4649157-A2 ACYLOIN CONDENSATION REACTIONS, ENZYMES, AND PRODUCTS THEREOF Mojia Biotech Pte. Ltd. (SG) 2025-11-19 EP disclosed
CN-120584179-A Extract containing mycosporine-glutamine 株式会社日水 2025-09-02 CN disclosed
EP-1282594-A1 BRANCHED AMINO ACIDS Medivir UK Ltd (GB) 2003-02-12 EP disclosed
WO-2001087821-A1 BRANCHED AMINO ACIDS MEDIVIR UK LIMITED (GB) 2001-11-22 WO disclosed
EP-1077692-A1 AMINO ACID STABILIZED GABAPENTIN AND PREGABALIN PREPARATIONS AND PROCESS FOR PREPARING THE SAME Warner-Lambert Company LLC (US) 2001-02-28 EP disclosed
WO-1999059573-A1 STABILIZED PHARMACEUTICAL PREPARATIONS OF GAMMA-AMINOBUTYRIC ACID DERIVATIVES AND PROCESS FOR PREPARING THE SAME WARNER-LAMBERT COMPANY (US) 1999-11-25 WO disclosed
EP-0042626-B1 ANTICONVULSIVE COMPOSITIONS NEW YORK UNIVERSITY (US) 1986-05-21 EP disclosed
US-4372974-A Anticonvulsive compositions and method of treating convulsive disorders NEW YORK UNIVERSITY (US) 1983-02-08 US disclosed
US-4322440-A Anticonvulsive compositions and method of treating convulsive disorders NEW YORK UNIVERSITY (US) 1982-03-30 US disclosed
EP-0042626-A2 Anticonvulsive compositions NEW YORK UNIVERSITY (US) 1981-12-30 EP disclosed